China – Page 2 – media

New Data Management Regulations Creates Hindrance for International Pharma Companies in China

According to the report, the new legislation could create various pitfalls for partnerships and research projects as well as increase the fees for the cost of entry into the Chinese pharma market. The new ordinances come after another extensive cyber-security law, which was set in place last year, stating that data must be hosted on servers on the Chinese mainland.
- Source: Fierce Pharma
- 630
- June 11, 2018
China Market Views medical device products pharmaceutical company USA
Zhifei Biological Products, the 2018 Richest Drug Maker in China

Merck & Co, developer of Gardasil and Gardasil 9 which recently got approved by Chinese authorities, have earned millions of dollars for their Zhifei Biological Products. It has also spurred two Chinese families into Bloomberg’s ranking of the world richest people.
- Source: Ddu
- 676
- June 1, 2018
China Market Views Merck
Healthcare Innovation Led By US and China

Global healthcare is being led by the US with China following close behind. Europe is simply being a spectator to the developments that are unfolding on a global level.
- Source: Ddu
- 737
- May 29, 2018
China healthcare Market Views USA
Rise in China’s Global Pharma Market up to $175 billion by 2022 – Market Prediction

Though the US stands first in the race in terms of sales and growth, it is highly believed that China would reach the peak in the pharma market by 2022. At present, since there has been a decrease in public health funding, there has been a slight fall in pharmerging countries like Brazil, Russia, India and China (BRIC). But it is believed that the condition of these pharmerging countries will improve in the next five years [1].
- Source: Ddu
- 823
- May 24, 2018
China Market Views pharmaceutical drugs
Digital Health Card on WeChat

Patients and Beijing residents are currently benefitting from the new electronic health cards issued by Beijing through the WeChat app; the program is facilitated by Tencent and Sinosoft Technology which is aimed to improve the healthcare services by 2030 through digital cards.
- Source: drugdu
- 773
- May 23, 2018
China digital health New Approvals
Huge biologics plant planned to be built by Sinobioway Biomedicine

Plans are afoot at Shandong Sinobioway Biomedicine Co. in China to construct a huge biologics plant as the country moves towards cell-based drugs.
- Source: drugdu
- 857
- May 15, 2018
biopharmaceutical China Market Views
Big Events on Pharmaceuticals during NPC & CPPCC

The two sessions (NPC & CPPCC) this year have received much attention from China and outside China, wherein, the most-watched theme is “reform”. Regarding pharmaceuticals, the event that attracts the highest attention is CFDA reform, followed by policy moves of the TCM issue and bio-medicine, etc. that China has been strongly supporting in recent years.
- Source: EN-CPhI
- 1,122
- March 26, 2018
CFDA China CPhI pharmaceutical Policies
U.K. Startup Medopad Signs Deals with Tencent and Ping An

London-based startup accompanying U.K. Prime Minister on trade mission
- Source: Bloomberg Technology
- 563
- February 1, 2018
AI China Company Insight digital health
China’s digital healthcare transformation – private hospital achieve HIMSS milestone

Explosive growth and groundbreaking digital transformations are underway in China’s enormous healthcare market, and now a Beijing hospital has become the first private healthcare organisation in the nation to achieve Stage 6 on the HIMSS EMRAM scale for its electronic medical record system.
- Source: Healthcare IT
- 532
- January 25, 2018
China health IT healthcare Market Views
Streamlined CFDA Review Process — New Opportunities in China

The Draft Amendment to Order 650 published by CFDA last month brings some good news around the streamlined reviews of medical device submissions in China and especially for manufacturers of Innovative Devices. Not only will manufacturers of innovative medical devices be exempted from providing proof of sales abroad to CFDA, the mandatory local type testing requirements are also abolished. Nevertheless, there still exist some challenges for the unwary.
- Source: brandwoodbiomedical
- 646
- December 8, 2017
CFDA China medical device

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.